A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00355355 |
|
Recruitment Status :
Completed
First Posted : July 21, 2006
Last Update Posted : January 30, 2015
|
Sponsor:
Light Sciences Oncology
Information provided by (Responsible Party):
Light Sciences Oncology
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | September 2012 |
| Actual Study Completion Date : | September 2012 |
| Certification/Extension First Submitted : | December 19, 2014 |